HomeTCRT • NASDAQ
add
Alaunos Therapeutics Inc
Previous close
$2.36
Day range
$2.30 - $2.44
Year range
$1.93 - $32.85
Market cap
3.78M USD
Avg Volume
15.31K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.01M | -71.86% |
Net income | -1.13M | 86.70% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.15M | 82.46% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.68M | -85.91% |
Total assets | 3.55M | -81.74% |
Total liabilities | 826.00K | -85.09% |
Total equity | 2.72M | — |
Shares outstanding | 1.60M | — |
Price to book | 1.39 | — |
Return on assets | -69.88% | — |
Return on capital | -88.53% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.13M | 86.70% |
Cash from operations | -781.00K | 87.75% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -781.00K | 87.75% |
Free cash flow | -371.75K | 90.53% |
About
Founded
1998
Website
Employees
1
